Manufacturer
Idorsia Pharmaceuticals
- Products listed
- 3
- Molecules
- 2
- Therapy areas
- 2
Idorsia Pharmaceuticals is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 3 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Idorsia Pharmaceuticals Ltd
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Idorsia Pharmaceuticals products through licensed channels, with the documents your regulator needs.
Psychiatry
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Quviviq 25 mg tabletOral | Daridorexant | US FDA | Available on request |
| Quviviq 50 mg tabletOral | Daridorexant | US FDA | Available on request |
Cardiology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Tryvio 12.5 mg tabletOral | Aprocitentan | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Idorsia Pharmaceuticals
Send a request for any of these products. We confirm the licensed source, documents and lead time.